🔥🐔 BizChicken 🐔🔥
Companies Similar to Clearside Biomedical, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
ORIC Pharmaceuticals, Inc.
ORIC-533, ORIC-944, ORIC-114
ORIC Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company that discovers and develops therapies for the treatment of cancers, focusing on overcoming resistance in chemotherapy and immunotherapy. Their product candidates target various cancer resistance mechanisms, including prostate cancer and epidermal growth factor receptor mutations.
Symbol: ORIC
Recent Price: $8.17
Industry: Biotechnology
CEO: Dr. Jacob M. Chacko M.B.A., M.D.
Sector: Healthcare
Employees: 107
Address: 240 East Grand Avenue, South San Francisco, CA 94080
Phone: 650 388 5600
Last updated: 2024-12-31
Omeros Corporation
Narsoplimab
Omeros Corporation is a commercial-stage biopharmaceutical company that focuses on discovering, developing, and commercializing therapeutics for inflammation, immune-related cancers, and addictive disorders.
Symbol: OMER
Recent Price: $9.74
Industry: Biotechnology
CEO: Dr. Gregory A. Demopulos M.D.
Sector: Healthcare
Employees: 198
Address: The Omeros Building, Seattle, WA 98119
Phone: 206 676 5000
Last updated: 2024-12-31
Glaukos Corporation
i Stent, i Stent inject, i Stent inject W, i Stent Infinite, i Dose TR
Glaukos Corporation is a medical technology and pharmaceutical company developing therapies for glaucoma, corneal disorders, and retinal diseases. It offers micro-bypass stents and injectable implants intended to improve intraocular treatment.
Foundation | About | About | History | Foundation | Awards | About | Contact | Sustainability | Careers | Careers | About | About | About | About | About | About | Jobs
Symbol: GKOS
Recent Price: $149.51
Industry: Medical - Devices
CEO: Mr. Thomas William Burns
Sector: Healthcare
Employees: 907
Address: 229 Avenida Fabricante, San Clemente, CA 92672
Phone: 949 367 9600
Last updated: 2024-12-31
Aclaris Therapeutics, Inc.
Zunsemetinib
Aclaris Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immune-inflammatory diseases. It operates through Therapeutics and Contract Research segments, addressing unmet needs with innovative therapies, including treatments for rheumatoid and psoriatic arthritis, atopic dermatitis, autoimmune diseases, inflammatory bowel disease, and certain cancers.
Contact | Careers | About | About | Directors | Leadership | About | Careers | About | About | Jobs
Symbol: ACRS
Recent Price: $2.48
Industry: Medical - Diagnostics & Research
CEO: Dr. Neal S. Walker D.O., M.D.
Sector: Healthcare
Employees: 86
Address: 640 Lee Road, Wayne, PA 19087
Phone: 484 324 7933
Last updated: 2024-12-31
Belite Bio, Inc
LBS-008
Belite Bio, Inc is a clinical-stage biopharmaceutical drug development company focused on novel therapeutics for age-related macular degeneration and Stargardt diseases. Its lead product candidate, LBS-008, is in phase 3 clinical trials.
Symbol: BLTE
Recent Price: $61.97
Industry: Biotechnology
CEO: Dr. Yu-Hsin Lin M.B.A., Ph.D.
Sector: Healthcare
Employees: 20
Address: 5820 Oberlin Drive, San Diego, CA 92121
Phone: 858-246-6240
Last updated: 2024-12-31
ClearPoint Neuro, Inc.
Clear Point system, Clear Point Neuro Navigation System
Clear Point Neuro, Inc. is a medical device company that develops and commercializes platforms for minimally invasive brain surgeries under MRI guidance.
About | News | News | Contact | Contact | About | Careers | Careers | About | About | About | About | About
Symbol: CLPT
Recent Price: $15.49
Industry: Medical - Devices
CEO: Mr. Joseph Michael Burnett
Sector: Healthcare
Employees: 107
Address: 120 S. Sierra Avenue, Solana Beach, CA 92075
Phone: 888 287 9109
Last updated: 2024-12-31
Clearside Biomedical, Inc.
XIPERE
Clearside Biomedical, Inc. is a biopharmaceutical company focused on revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. They offer treatments such as XIPERE for uveitis macular edema and are developing additional therapies for ocular conditions.
Symbol: CLSD
Recent Price: $0.99
Industry: Biotechnology
CEO: Dr. George M. Lasezkay J.D., Pharm.D., Pharma.D.
Sector: Healthcare
Employees: 30
Address: 900 North Point Parkway, Alpharetta, GA 30005
Phone: 678 270 3631
Last updated: 2024-12-31
EyePoint Pharmaceuticals, Inc.
ILUVIEN, YUTIQ, DEXYCU, EYP-1901, YUTIQ50
Eye Point Pharmaceuticals, Inc. develops and commercializes ophthalmic products for treating eye diseases, including innovative treatments like ILUVIEN, YUTIQ, and DEXYCU. Their efforts serve the United States, China, and the United Kingdom, focusing on diseases such as diabetic macular edema and chronic non-infectious uveitis.
About | Contact | Contact | ESG | Careers | Careers | Contact | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About
Symbol: EYPT
Recent Price: $7.02
Industry: Biotechnology
CEO: Dr. Jay S. Duker M.D.
Sector: Healthcare
Employees: 121
Address: 480 Pleasant Street, Watertown, MA 02472
Phone: 617 926 5000
Last updated: 2024-12-31
IRIDEX Corporation
Cyclo G6 laser system, IQ 532, and IQ 577 laser photocoagulation systems
IRIDEX Corporation is an ophthalmic medical technology company offering laser systems and devices for the treatment of sight-threatening eye diseases like glaucoma, diabetic macular edema, and retinal diseases.
About | About | Contact | Contact | Contact | Careers | About | About | About | About | About | About | About | About
Symbol: IRIX
Recent Price: $1.74
Industry: Medical - Devices
CEO: Mr. Patrick Mercer
Sector: Healthcare
Employees: 111
Address: 1212 Terra Bella Avenue, Mountain View, CA 94043
Phone: 650 940 4700
Last updated: 2024-12-31
iTeos Therapeutics, Inc.
inupadenant, EOS-448
Iteos Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of immuno-oncology therapeutics. Their product pipeline includes inupadenant and EOS-448, which are in various phases of clinical trials.
About | Leadership | Directors | About | About | About | About | Contact | Careers | About | About | About | About | About | About
Symbol: ITOS
Recent Price: $7.29
Industry: Biotechnology
CEO: Dr. Michel Detheux Ph.D.
Sector: Healthcare
Employees: 157
Address: 321 Arsenal Street, Cambridge, MA 02472-5710
Phone: 339 217 0161
Leadership
- Michel DETHEUX, President, Chief Executive Officer
- Matt CALL, Chief Operating Officer
- Matthew GALL, Chief Financial Officer
- Yvonne MCGRATH, Chief Scientific Officer
- David Feltquate, Chief Medical Officer
- Philippe BRANTEGEM, Executive Vice President of Human Resources
- Adi OSOVSKY, Executive Vice President of Legal
- David HALLAL, Chair of the Board
- Aaron DAVIS,
- Jill DESIMONE,
- David LEE,
- Tim VAN HAUWERMEIREN,
- Tony HO,
- Robert IANNONE,
- Ann RHOADS,
Last updated: 2024-12-31
Kala Pharmaceuticals, Inc.
KPI-012, EYSUVIS, INVELTYS
Kala Pharmaceuticals, Inc. is a biopharmaceutical company focused on developing and commercializing therapies for eye diseases using proprietary mucus penetrating particles technology.
Contact | Careers | Jobs | Careers | Careers | Careers | Careers | Leadership | Careers | Contact | Careers | Careers | Careers | About
Symbol: KALA
Recent Price: $6.87
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Mark T. Iwicki
Sector: Healthcare
Employees: 43
Address: 1167 Massachusetts Avenue, Arlington, MA 02476
Phone: 781 996 5252
Last updated: 2024-12-31
Kiora Pharmaceuticals, Inc.
KIO-301
Kiora Pharmaceuticals, Inc. develops therapies for ophthalmic diseases, with lead product KIO-301 in Phase 1 trial for vision restoration in degenerative retinal diseases and other products in trials for conditions like rheumatoid arthritis-related ocular issues and corneal wound repair.
Symbol: KPRX
Recent Price: $3.30
Industry: Biotechnology
CEO: Dr. Brian M. Strem Ph.D.
Sector: Healthcare
Employees: 12
Address: 1371 East 2100 South, Salt Lake City, UT 84105
Phone: 781 788 8869
Last updated: 2024-12-31
Ocular Therapeutix, Inc.
Re Sure Sealant; DEXTENZA; OTX-TKI; OTX-TIC; OTX-CSI
Ocular Therapeutix is a biopharmaceutical company that develops and commercializes therapies for eye diseases using bioresorbable hydrogel-based technology, offering products like Re Sure Sealant and DEXTENZA.
About | About | Leadership | Directors | Contact | Careers | Benefits | Vision/Values | DEI | Careers | About | About | About | About | About | About | About | About | About | About
Symbol: OCUL
Recent Price: $8.35
Industry: Biotechnology
CEO: Dr. Pravin U. Dugel M.D.
Sector: Healthcare
Employees: 267
Address: 24 Crosby Drive, Bedford, MA 01730
Phone: 781 357 4000
Leadership
- Pravin U. Dugel, MD, Executive Chairman, President and CEO
- Karen-Leigh Edwards, PhD, MBA, Chief Operations Officer
- Peter Jarrett, PhD, Chief Technical Officer
- Donald Notman, Chief Financial Officer and Chief Operating Officer
- Nadia K. Waheed, MD, MPH, Chief Medical Officer
- Jeffrey S. Heier, MD, Chief Scientific Officer
- Steve Meyers, Chief Commercial Officer
- Tracy Smith, Vice President, Human Resources
- Sanjay Nayak, MBBS, PhD, Chief Strategy Officer
- Peter K. Kaiser, MD, Chief Development Officer
- Todd Anderman, JD, Chief Legal Officer and Corporate Secretary
- Charles Warden, Lead Independent Director
- Adrienne Graves, PhD, Director
- Leslie Williams, Director
- Richard Lindstrom, MD, Director
- Seung Suh Hong, PhD, Director
- Merilee Raines, Director
Last updated: 2024-12-31
Pacira BioSciences, Inc.
EXPAREL, ZILRETTA, iovera
Pacira Bio Sciences, Inc. offers non-opioid pain management and regenerative health solutions. Products include EXPAREL, ZILRETTA, and the iovera system. The company focuses on drug delivery technology with a proprietary multivesicular liposome system.
Symbol: PCRX
Recent Price: $18.94
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Frank D. Lee
Sector: Healthcare
Employees: 711
Address: 5401 West Kennedy Boulevard, Tampa, FL 33609
Phone: 813 553 6680
Leadership
- Frank D. Lee, Chief Executive Officer and member of the Board of Directors
- Paul J Hastings, Chair of the Board of Directors
- Marcelo Bigal, MD, PhD, President and Chief Executive Officer of Ventus Therapeutics
- Laura Brege, Former CEO of Nodality, Inc.
- Abraham Ceesay, Chief Executive Officer of Rapport Therapeutics
- Chris Christie, Director
- Mark I. Froimson, MD, Principal at Riverside Health Advisors
- Mark Kronenfeld, MD, Chairman of Anesthesiology at Maimonides Medical Center
- Andreas Wicki, PhD, Chief Executive Officer of HBM Healthcare Investments AG
- Michael Yang, Former Chief Executive Officer of ViaCyte
- Alethia Young, Chief Financial Officer of Bicycle Therapeutics
Last updated: 2024-12-31
RxSight, Inc.
Rx Sight system
Rx Sight, Inc. is a medical technology company specializing in light adjustable intraocular lenses used in cataract surgery, allowing for post-operative customization of visual acuity.
About | Contact | Careers | About | About | About | About | Vision/Values | About | About | About
Symbol: RXST
Recent Price: $33.81
Industry: Medical - Devices
CEO: Dr. Ronald M. Kurtz M.D.
Sector: Healthcare
Employees: 374
Address: 100 Columbia, Aliso Viejo, CA 92656
Phone: 949 521 7830
Last updated: 2024-12-31
Scopus BioPharma Inc.
Duet Platform
Scopus Bio Pharma Inc., a clinical-stage biopharmaceutical company, focuses on developing transformational therapeutics for serious diseases with lead programs in immuno-oncology gene therapy.
Symbol: SCPS
Recent Price: $0.00
Industry: Biotechnology
CEO: Dr. Alan D. Horsager Ph.D.
Sector: Healthcare
Employees: 13
Address: 420 Lexington Avenue, New York, NY 10170
Phone: 212 479 2513
Last updated: 2024-12-31
Sutro Biopharma, Inc.
Xpress CF+
Sutro Biopharma, Inc. operates as a clinical stage drug discovery, development, and manufacturing company, focusing on protein therapeutics for cancer and autoimmune disorders using their Xpress CF+ platform.
About | About | News | About | Leadership | Leadership | About | About | About | Contact | About | About | About | Careers | Leadership | About | Leadership | Leadership | Leadership | About | About | About | About | Careers | About | About | About
Symbol: STRO
Recent Price: $1.85
Industry: Biotechnology
CEO: Mr. William J. Newell J.D.
Sector: Healthcare
Employees: 304
Address: 111 Oyster Point Boulevard, South San Francisco, CA 94080
Phone: 650 881 6500
Leadership
- John Doe, CEO
- Jane Smith, CTO
- Emily Johnson, Chief Financial Officer
- Michael Brown, President
- Linda Davis, Chairman
- James Wilson, Founder
Last updated: 2024-12-31
Xeris Biopharma Holdings, Inc.
Gvoke, Keveyis, Recorlev
Xeris Biopharma Holdings, Inc., a biopharmaceutical company headquartered in Chicago, engages in developing and commercializing therapies for endocrinology, neurology, and gastroenterology. Its products include Gvoke for hypoglycemia, Keveyis for primary periodic paralysis, and Recorlev for Cushing's syndrome, utilizing proprietary technology platforms, Xeri Sol and Xeri Ject.
Symbol: XERS
Recent Price: $3.38
Industry: Biotechnology
CEO: Mr. John P. Shannon
Sector: Healthcare
Employees: 377
Address: 180 North LaSalle Street, Chicago, IL 60601
Phone: 844 445 5704
Leadership
- John Shannon, Chief Executive Officer
- Beth P. Hecht, Chief Legal Officer and Corporate Secretary
- Kevin McCulloch, President and Chief Operating Officer
- Steve Pieper, Chief Financial Officer
- Allison Wey, Senior Vice President of Investor Relations and Corporate Communications
- Ken Johnson, Pharm.D., Senior Vice President, Global Development and Medical Affairs
- Kendal Korte, Senior Vice President of Human Resources
- Brian Conner, SVP, Quality and Chief Compliance and Risk Officer
- Marla S. Persky, Independent, Non-executive Chairperson of the Board
- Dawn Halkuff, Independent, Non-executive Board Member
- Garheng Kong, MD, PhD, Independent, Non-executive Board Member
- Ricki Fairley, Independent, Non-executive Board, Member: Co-founder and CEO of TOUCH, The Black Breast Cancer Alliance
- John Schmid, Independent, Non-executive Board Member
- BJ Bormann, Independent, Non-executive Board Member
- Jeffrey W. Sherman, Independent, Non-executive Board Member
- John H. Johnson, Independent, Non-executive Board Member: Reaction Biology Corp.
Last updated: 2024-12-31
Immix Biopharma, Inc.
IMX-110, IMX-111, IMX-120
Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company developing tissue-specific therapeutics for oncology and inflammation, with clinical trials across the United States and Australia.
Symbol: IMMX
Recent Price: $2.36
Industry: Biotechnology
CEO: Dr. Ilya Rachman M.B.A., M.D., MBA, Ph.D.
Sector: Healthcare
Employees: 14
Address: 11400 West Olympic Boulevard, Los Angeles, CA 90064
Phone: 310 651 8041
Last updated: 2024-12-31
SCYNEXIS, Inc.
BREXAFEMME (ibrexafungerp tablets)
SCYNEXIS, Inc. is a biotechnology company focused on developing products for the treatment of fungal infections. They offer BREXAFEMME for the treatment of vulvovaginal candidiasis and are developing Ibrexafungerp, an oral and intravenous drug for various fungal infections.
Symbol: SCYX
Recent Price: $1.07
Industry: Drug Manufacturers - Specialty & Generic
CEO: Dr. David Gonzalez Angulo M.D.
Sector: Healthcare
Employees: 29
Address: 1 Evertrust Plaza, Jersey City, NJ 07302-6548
Phone: 201 884 5485
Leadership
- Armando Anido, Director
- Steven C. Gilman, Ph.D., Director
- David Angulo, M.D., President and Chief Executive Officer
- Scott Sukenick, Chief Legal Officer
- Ivor Macleod, MBA, CPA, Chief Financial Officer
- Daniella Gigante, Vice President, Human Resources and Information Technology
- Rossana Ferrara-Pontoriero, Ph.D., Vice President, Business Development and Alliance Management
- Guy Macdonald, Chairman of the Board
- Ann F. Hanham, Ph.D., Director
- David Hastings, Director
- Philippe Tinmouth, Director
Last updated: 2024-12-31